. Polymorphisms in the gene encoding the cytokine thymic stromal lymphopoietin (TSLP) are associated with the development of multiple allergic disorders in humans, indicating that TSLP is a critical regulator of T H 2 cytokineassociated inflammatory diseases [3] [4] [5] [6] . In support of genetic analyses, exaggerated TSLP production is associated with asthma, atopic dermatitis and food allergies in patients, and studies in murine systems demonstrated that TSLP promotes T H 2 cytokine-mediated immunity and inflammation 5, [7] [8] [9] [10] [11] [12] . However, the mechanisms through which TSLP induces T H 2 cytokine responses remain poorly defined. Here we demonstrate that TSLP promotes systemic basophilia, that disruption of TSLP-TSLPR interactions results in defective basophil responses, and that TSLPR-sufficient basophils can restore T H 2-celldependent immunity in vivo. TSLP acted directly on bone-marrowresident progenitors to promote basophil responses selectively. Critically, TSLP could elicit basophil responses in both IL-3-IL-3R-sufficient and -deficient environments, and genome-wide transcriptional profiling and functional analyses identified heterogeneity between TSLP-elicited versus IL-3-elicited basophils. Furthermore, activated human basophils expressed TSLPR, and basophils isolated from eosinophilic oesophagitis patients were distinct from classical basophils. Collectively, these studies identify previously unrecognized heterogeneity within the basophil cell lineage and indicate that expression of TSLP may influence susceptibility to multiple allergic diseases by regulating basophil haematopoiesis and eliciting a population of functionally distinct basophils that promote T H 2 cytokinemediated inflammation.
Previous in vitro studies suggested that TSLP could promote T H 2 cytokine-mediated inflammation by influencing dendritic cell, mast cell and lymphocyte populations 13 . However, the IL-4-expressing cell populations that TSLP targets in vivo remain poorly defined. Following administration of recombinant TSLP (rTSLP) to IL-4/eGFP (enhanced green fluorescent protein) reporter mice, an increase in the frequency and total number of basophils was observed in the spleen (Fig. 1a, b) . Mice receiving hydrodynamic tail vein injections of cDNA plasmid encoding TSLP (TSLP cDNA) 14 also exhibited significant increases in the frequency and total number of basophils in the spleen (Fig. 1c, d ), blood, lung and bone marrow ( Supplementary Fig. 1a-f) . Basophils, along with dendritic cells, are capable of contributing to the induction of optimal T H 2 cytokine responses [15] [16] [17] [18] [19] [20] . Consistent with this, exaggerated basophil responses in TSLP-cDNA-treated mice were associated with increased systemic production of T H 2 cytokines mice were treated with PBS or rTSLP and splenic basophils were identified (a) and quantified (b). c, d, Wild-type mice were treated with control cDNA or TSLP-encoding (TSLP cDNA) plasmid and splenic basophils were identified (c) and quantified (d). e-h, Serum IL-4 (e), IL-5 (f), IL-13 (g) and total IgE (h) were quantified. i, Histological analysis of small intestine. Scale bars, 100 mm. j, Splenic basophils from control mice (WT), or SPC-TSLP mice were identified. Flow cytometry plots are gated on live NBNT cells. Results are representative of at least three (a-d and j-i) or two (e-i) separate experiments containing 3-5 (a-d), 5 (e-i) or 6-12 (j) mice per group. Results are shown as means 6 s.e.m. Statistical analyses performed using a two-tailed students t-test (*P , 0.05), (**P , 0.01).
( Fig. 1e-g ), elevated IgE levels (Fig. 1h ) and the development of T H 2 cytokine-associated intestinal inflammation (Fig. 1i) . In addition to reported expression by mast cells and basophils, epithelial cells at barrier surfaces are potent sources of TSLP 13 . Therefore, we tested whether epithelial-cell-derived TSLP could influence peripheral basophil populations. Mice that constitutively express a Tslp transgene under the surfactant protein C promoter (SPC-TSLP) in lung epithelial cells 21 exhibited increased frequencies of basophils in the spleen (Fig. 1j) .
To test whether TSLP-TSLPR signalling influences infectioninduced basophilia in vivo, we used a helminth model in which protective immunity is dependent on TSLP-TSLPR signalling 10 . Whereas Trichuris muris-infected wild-type mice exhibited increased basophils in the periphery, Tslpr 2/2 mice failed to exhibit infection-induced basophilia ( Supplementary Fig. 2a) . Critically, TSLP-elicited basophils isolated from Tslpr 1/1 mice and adoptively transferred into normally susceptible T. muris-infected Tslpr 2/2 mice were sufficient to restore T H 2 cytokine responses ( Supplementary Fig. 2b,c) , IgE production ( Supplementary Fig. 2d ), goblet cell hyperplasia ( Supplementary Fig.  2e, f) , secretion of goblet-cell-derived RELM-b ( Supplementary Fig. 2g ) and significantly reduce worm burdens ( Supplementary Fig. 2h ). These data demonstrate that basophil-restricted TSLPR expression is sufficient to partially restore protective T H 2 cytokine responses in vivo.
TSLP was originally identified as a lymphocyte growth factor capable of regulating the differentiation of lymphocytes from haematopoietic progenitor cells 13 . These findings provoked the hypothesis that in addition to influencing peripheral basophil responses, TSLP may regulate basophil haematopoiesis in the bone marrow. To test directly whether TSLP could elicit the population expansion of basophils from bone-marrow-resident cells, we adopted a basophil differentiation assay using IL-4/eGFP reporter mice 22 . When bone marrow was cultured in media alone, 4.25% of the non-B non-T (NBNT) cells expressed IL-4/eGFP (Fig. 2a) , but no mast cells or basophils were present (Fig. 2b ). As previously reported 22 , bone marrow cells cultured in the presence of IL-3 exhibited increased frequencies of IL-4/eGFP 1 NBNT cells (17.6%) (Fig. 2c ) and increased mast cell and basophil populations (Fig. 2d) . In contrast, TSLP-stimulated bone marrow cultures yielded increased frequencies of IL-4/eGFP 1 cells (7.13%) ( Fig. 2e ) and basophils but did not yield mast cell populations (Fig. 2f) . Consistent with these data, bone marrow from wild-type mice cultured in the presence of IL-3 exhibited increased frequencies and total numbers of basophils and mast cells, whereas bone marrow cultured in the presence of TSLP alone exhibited increased frequencies and total numbers of basophils but not mast cells ( Supplementary  Fig. 3a-h ). Collectively, these data illustrate that TSLP can elicit the selective population expansion of mature basophils from bonemarrow-resident cells.
Basophil populations develop from precursors (BaP) that are characterized as CD34 . BaPs isolated from bone marrow expressed both chains of the TSLPR complex (IL-7Ra and TSLPR), indicating that they may be TSLP-responsive (Supplementary Fig. 4a ). To test whether IL-3 or TSLP could induce basophil maturation, sorted bone-marrow-resident BaPs ( Supplementary  Fig. 4b ) were cultured in the presence of media, IL-3 or TSLP and mature basophil populations were evaluated on day 5 after culture. Greater than 30% of BaPs cultured in the presence of media alone retained their progenitor-like phenotype as measured by expression of CD34 ( Supplementary Fig. 4c ). In contrast, IL-3-stimulated BaPs were predominantly CD34 2 and exhibited elevated CD49b expression, a phenotype consistent with mature basophils ( Supplementary  Fig. 4c, d ). Critically, TSLP-stimulated BaPs were also predominantly CD34 2 and exhibited elevated levels of CD49b expression (Supplementary Fig. 4c, d ). Consistent with whole bone marrow cultures (Fig. 2d, f) , IL-3-or TSLP-treated cell cultures yielded more basophils than media alone controls, and IL-3-elicited basophils were larger in size than TSLP-elicited basophils ( Supplementary Fig. 4e, f) . To compare the ability of IL-3 or TSLP to enhance basophil survival, mature basophils were sort-purified from the blood and spleen of wild-type mice and cultured in the presence of media, IL-3 or TSLP for 24 h. Whereas most mature basophils died when cultured in media alone, 24.6% of basophils survived in the presence of IL-3 and 13.1% of the basophils survived in the presence of TSLP (Supplementary Fig. 5a ). These data demonstrate that both IL-3 and TSLP can promote basophil maturation from bone-marrow-resident precursor cells and promote survival of mature basophils isolated from the periphery.
IL-3 is reported to be essential for optimal basophil activation, population expansion and survival 24 . To test whether TSLP-elicited basophil responses were dependent on IL-3-IL-3R signalling, bone marrow cells from wild-type mice or mice deficient in both IL-3Rbil3 and IL3Rbc (Csf2rb2
) 25 were cultured in the presence of media, IL-3 or TSLP. Addition of IL-3 to wild-type bone marrow cultures increased the frequency of basophils compared to media alone controls (Fig. 3a) , whereas the addition of IL-3 to Csf2rb2
Csf2rb
2/2 bone marrow cultures had no effect on basophil populations (Fig. 3b) . Similar to IL-3 stimulation, addition of TSLP to wild-type bone marrow cultures increased the frequency of basophils (Fig. 3a) . Critically, addition of TSLP to Csf2rb2
2/2 bone marrow cultures also increased the frequency of basophils (Fig. 3b) , demonstrating that TSLP can promote the population expansion of basophils from bone marrow cells independently of IL-3-IL-3R signalling. However, basophils were readily identified in the spleen and bone marrow of Csf2rb2 
2/2 mice treated with neutralizing anti-TSLP monoclonal antibody ( Supplementary Fig. 5b, c) , demonstrating that signalling via IL-3-IL-3R and TSLP-TSLPR is not essential for basophil development. To test whether TSLP could elicit mature basophil responses independently of IL-3-IL-3R signalling in vivo, wild-type or Csf2rb2
2/2 mice were injected with PBS or rTSLP and peripheral basophil responses were examined. TSLP-treated wild-type mice exhibited increased frequencies and total numbers of basophils 
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in the blood (Fig. 3c, d ) and spleen (Fig. 3g, h ) compared to PBS treated controls. Critically, rTSLP treatment significantly increased both the frequency and total number of basophils in the blood (Fig. 3e, f) and spleen (Fig. 3i, j) of Csf2rb2
Csf2rb
2/2 mice. Collectively, these data illustrate that TSLP promotes peripheral basophilia in both IL-3-IL-3R-sufficient and -deficient environments.
To test if IL-3-elicited versus TSLP-elicited basophil populations were phenotypically distinct, flow cytometric analysis of basophilassociated surface markers was performed. Whereas IL-3-elicited and TSLP-elicited basophils exhibited similar expression of CD200R and CD69, IL-3-elicited basophils exhibited elevated expression of CD11b and CD62L (Fig. 4a) . In contrast, TSLP-elicited basophils exhibited elevated expression of CD123, IL-33R (also called T1/ST2) and IL-18Ra (Fig. 4b) . Collectively, these data demonstrate that IL-3-versus TSLP-elicited basophils exhibit distinct surface marker expression. Genome-wide transcriptional profiling of IL-3-elicited versus TSLP-elicited basophils also revealed remarkable differences in patterns of gene expression between the two basophil populations. Gene-set enrichment analysis (GSEA) 26 of complete transcriptional profiles revealed that IL-3-elicited basophils reflected gene expression associated with monocyte and dendritic cell maturation, matrix metalloproteinase production and tumour-necrosis factor-a (TNF-a) signalling (Fig. 4c and Supplementary Fig. 6 ). In contrast, TSLP-elicited basophils exhibited a gene expression profile enriched for linoleic acid metabolism, arachidonic acid metabolism, cell communication and the expression of cell adhesion molecules (Fig. 4c and Supplementary  Fig. 6 ). Real-time PCR analysis also revealed selective differential expression of messenger RNA encoding basophil-associated proteases mast cell protease 2 (Mcpt2) and Mcpt7 (also called Tpsab1) between the two populations ( Supplementary Fig. 7a ). Collectively, these results demonstrate phenotypic heterogeneity between IL-3-elicited versus TSLP-elicited basophils and indicate that either the two basophil populations represent distinct developmental stages of basophils or that they are functionally heterogeneous mature basophil populations.
To test whether phenotypic differences in the two basophil populations were associated with functional heterogeneity, a panel of basophil activation assays was used. IL-3-elicited basophils exhibited similar degranulation and b-hexosaminidase release 27 (a hallmark of basophil effector function 28 ) as mast cells in response to IgE-mediated FceRI crosslinking ( Supplementary Fig. 7b ). Consistent with distinct effector functions, TSLP-elicited basophils exhibited minimal degranulation ( Supplementary Fig. 7b ). Surface marker expression on IL-3-elicited versus TSLP-elicited basophils indicated that these two populations may differ in their responsiveness to cytokines (Fig. 4b) . To test this directly, IL-3-or TSLP-elicited basophils were sort-purified and stimulated with media alone, IL-3, IL-18 or IL-33, and production of cytokines and chemokines was assessed. Whereas the two basophil populations shared some functions including similar production of IL-1a and CCL11 ( Supplementary Fig. 8a, b) , TSLP-elicited basophils produced significantly more IL-4 and IL-6 ( Supplementary Fig. 8a ) and more CCL3, CCL4 and CCL12 ( Supplementary Fig. 8b ) in response to IL-3 stimulation compared to IL-3-elicited basophils. TSLPelicited basophils also produced significantly more IL-4, IL-6, TNF-a ( Supplementary Fig. 8a ), CCL3, CCL4, CCL9, CCL12 ( Supplementary  Fig. 8b ) and CXCL2 ( Supplementary Fig. 8c ) in response to IL-18 stimulation when compared to IL-3-elicited basophils. Finally, TSLPelicited basophils produced more IL-4, IL-6 ( Supplementary Fig. 8a ), CCL3, CCL12 (Supplementary Fig. 8b ) and CXCL2 ( Supplementary  Fig. 8c ) in response to IL-33 stimulation than IL-3-elicited basophils. Collectively, these data indicate that IL-3-elicited and TSLP-elicited basophils exhibit distinct responsiveness and functional potential after stimulation with IL-3, IL-18 or IL-33.
To test whether IL-3-independent, TSLP-dependent basophil responses exist in vivo following exposure to an inflammatory stimulus, a TSLP-dependent murine model of atopic dermatitis 29 was used. Topical treatment with the vitamin D analogue MC903 resulted in increased levels of TSLP (Supplementary Fig. 9a ). Furthermore, MC903 treatment resulted in the accumulation of basophils in the skin of wild-type mice (Supplementary Fig. 9b ). MC903-induced basophil responses were TSLP-dependent, as treatment of wild-type mice with anti-TSLP diminished the accumulation of basophil populations (Supplementary Fig. 9b ). MC903 treatment of Csf2rb2
mice also resulted in a robust accumulation of basophils in the skin (Supplementary Fig. 9c) , and MC903-induced, IL-3-independent basophil responses were significantly reduced after anti-TSLP treatment (Supplementary Fig. 9c ). Collectively, these data demonstrate IL-3-independent, TSLP-dependent basophil responses in vivo. To test whether TSLP-dependent basophils contribute to the induction of T H 2 
2/2 1 TSLP, n 5 7). Results are shown as means 6 s.e.m. Statistical analysis was performed using a two-tailed students t-test (*P , 0.05).
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cell responses, MC903 treatment of wild-type mice was extended to 7 days. MC903 treatment resulted in the robust accumulation of basophils in the skin (Supplementary Fig. 9d ) and a marked increase in IL-4 and IL-5 production in the draining lymph nodes (Supplementary Fig.  9f ). Critically, diphtheria-toxin-mediated depletion of basophils 30 reduced the accumulation of basophils in the skin ( Supplementary  Fig. 9e ) and decreased IL-4 and IL-5 production ( Supplementary  Fig. 9f ), demonstrating that TSLP-dependent basophils contribute to T H 2 cytokine responses in vivo.
To test whether human basophils can respond to TSLP, peripheral blood from healthy human donors was taken and TSLPR expression on basophils was evaluated. Greater than 70% of activated peripheral human basophils expressed TSLPR (Fig. 4d) , indicating that human basophils can be TSLP-responsive. The food-allergy-associated disease eosinophilic oesophagitis is associated with gain-of-function polymorphisms in the gene encoding TSLP and elevated expression of TSLP [3] [4] [5] [6] 13 . To examine whether basophil heterogeneity exists when human basophils develop in a TSLP-rich environment associated with food allergy, basophil responses were examined in healthy control or eosinophilic oesophagitis patients. No differences in expression of HLA-DR, CD28, CD40, CD86, CD69 or CD203c were observed between control and eosinophilic oesophagitis patients (data not shown). However, consistent with TSLP-induced basophils in mice, basophils from eosinophilic oesophagitis patients expressed significantly higher levels of IL-33R compared to basophils from healthy controls (Fig. 4e, f) . These data indicate that heterogeneity in basophil populations may exist in humans and correlates with susceptibility to allergic inflammation.
Collectively, these data identify that TSLP can selectively promote basophil haematopoiesis from bone-marrow-resident precursors and elicit mature basophil responses in the periphery in an IL-3-IL-3R-sufficient or -deficient environment. The demonstration that TSLPelicited basophils exhibit divergent transcriptional and functional profiles from IL-3-elicited basophils indicates that similar to other immune cell lineages, basophils are a heterogeneous cell population that exhibit distinct phenotypic and functional characteristics depending on the cytokine environment in which they develop or are activated. The identification of a role for TSLP in promoting basophil haematopoiesis, peripheral basophilia and altering the functional capacity of basophils ( Supplementary Fig. 10 ) may provide a biological mechanism through which local production of TSLP at one barrier surface can confer susceptibility to pan-allergic diseases at multiple mucosal sites.
METHODS SUMMARY
C57BL/6 or BALB/c wild-type, IL-4/eGFP reporter or Csf2rb2
Csf2rb
2/2 mice were treated by intraperitoneal (i.p.) injection with PBS or 10 mg of rTSLP daily for 4-7 days and basophil populations were evaluated. Mice were injected intravenously (i.v.) with 10 mg of control or TSLP encoding cDNA plasmid and basophils (day 21) and small intestine pathology (day 28) were evaluated after injection. Wild-type and Tslpr 2/2 mice were infected with T. muris and on day 10 after infection, one group of Tslpr 2/2 mice received 100 3 10 3 TSLPR-sufficient basophils elicited from TSLP-cDNA-injected H2K-Bcl2-transgenic mice. All groups received 10 mg injections of rTSLP every other day starting at day 11 after infection. On day 21 after infection, T H 2 cytokine responses, serum IgE, pathology, RELM-b and worm burdens were evaluated. Bone marrow from wild-type, IL-4/eGFP reporter or Csf2rb2
2/2 mice was cultured in the presence of 10 ng ml 21 of IL-3 or 1 mg ml 21 of TSLP for 5 days. Bone-marrow-derived basophils were sorted on day 5 after culture, RNA was isolated and gene expression profiles were determined using an Affymetrix HT Mouse 430 PM platform, and analysis was performed using GSEA software through http://www.broadinstitute.org/gsea/ index.jsp. Bone-marrow-resident BaPs were sorted from wild-type whole bone marrow and cultured in the presence of 10 ng ml 21 of IL-3 or 1 mg ml 21 of TSLP for 5 days and basophils were evaluated by flow cytometry and cytology. Wildtype, Csf2rb2 2/2 Csf2rb
, or BaS-TRECK mice were treated with 50 ml of 100% ethanol or 50 ml of 2 nm MC903 dissolved in 100% ethanol topically for 3-7 days. Groups were treated (i.p.) with 1 mg of rat IgG isotype control or anti-TSLP antibody on day 0 of ethanol or anti-MC903 treatment. Skin-draining lymph node cells were isolated from ethanol-treated or MC903-treated mice on day 7 and stimulated with anti-CD3 and anti-CD28 for 48 h. RESEARCH LETTER
